Lead Product(s) : Diperoxochloric Acid
Therapeutic Area : Podiatry
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Centaur Pharma Launches Novel Topical Solution WoxHeal for the Treatment of Diabetic Foot Ulcer
Details : WOXheal has dual mechanism of action, i.e. it has functional antibacterial action against Gram positive and gram negative bacteria and it also promotes growth of fibroblast cells, thereby yielding complete wound closure.
Product Name : WOXheal
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 10, 2020
Lead Product(s) : Diperoxochloric Acid
Therapeutic Area : Podiatry
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
